doi: 10.1016/j.eprac.2021.04.001 Summary Keywords semaglutide, overweight, obese, meta-analysis, subgroup Citation Zhang R, Hou Q, Li B, Deng L, Yang Y, Li T, Yao X, Yang L, Lin X, Liao Y, Wang L, Liu Y, Tan J, Wan Z and Shuai P (2023) Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials
The pharmacists said that they would dispense the remaining stock and hoped to continue providing patients with prescriptions through the end of the year
Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: a randomized controlled trial
All six experienced adverse events, mostly nausea and stomach issues
KEY POINTS ABOUT SEMAGLUTIDE Mechanism of Action: Semaglutide works by mimicking the action of GLP-1 in the body